Cutaneous mastocytosis is a form of mastocytosis that primarily affects the skin. There are three main forms of the condition: maculopapular cutaneous mastocytosis (also called urticaria pigmentosa), solitary cutaneous mastocytoma, and diffuse cutaneous mastocytosis.
This report contains market size and forecasts of Cutaneous Mastocytosis Treatment in Global, including the following market information:
Global Cutaneous Mastocytosis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cutaneous Mastocytosis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antihistamines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cutaneous Mastocytosis Treatment include Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Johnson & Johnson and Bayer AG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cutaneous Mastocytosis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cutaneous Mastocytosis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cutaneous Mastocytosis Treatment Market Segment Percentages, by Type, 2021 (%)
Antihistamines
Corticosteroids
Mast Cell Stabilizers
Sympathomimetic Agents (Ephinephrine)
Photochemotherapy
Global Cutaneous Mastocytosis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cutaneous Mastocytosis Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Cutaneous Mastocytosis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cutaneous Mastocytosis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cutaneous Mastocytosis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cutaneous Mastocytosis Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Johnson & Johnson
Bayer AG
Mallinckrodt Pharmaceuticals